Edward van der Horst
Technik-/Wissenschafts-/F&E-Leiter bei SENSEI BIOTHERAPEUTICS, INC.
Vermögen: 56 070 $ am 30.04.2024
Aktive Positionen von Edward van der Horst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.12.2022 | - |
| Corporate Officer/Principal | 01.09.2019 | 07.12.2022 |
Karriereverlauf von Edward van der Horst
Ehemalige bekannte Positionen von Edward van der Horst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Zenith Epigenetics Ltd.
 Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Corporate Officer/Principal | 01.07.2017 | 01.08.2019 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | 01.10.2010 | 01.01.2017 |
Ausbildung von Edward van der Horst
| Ludwig-Maximilians-Universität München | Graduate Degree |
| Max Planck Institute of Biochemistry | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Deutschland | 3 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Zenith Epigenetics Ltd.
Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Commercial Services |
- Börse
- Insiders
- Edward van der Horst
- Erfahrung
